Actively Recruiting
Investigating Frailty and Inflammatory Biomarkers in Elderly Hip Fracture Patients Treated with Surgery
Led by University of Thessaly · Updated on 2026-05-05
200
Participants Needed
2
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Frailty is a common condition among elderly patients who have hip fractures and is linked to worse outcomes. Researchers are studying whether hip fracture patients who have frailty show higher levels of inflammation based on simple blood tests measuring inflammatory biomarkers. This observational study aims to understand the relationship between frailty and inflammation in this group of patients. The study observes hip fracture patients who are treated with surgery. Frailty will be assessed using the Groningen Frailty Indicator, a validated tool. No experimental treatments are given rather, the study collects data on patients frailty status and inflammatory markers before surgery to explore possible links. Participants will be evaluated before their surgery with assessments of their frailty status and blood tests for inflammatory biomarkers. Researchers will gather information on these markers and frailty to analyze potential associations. The study is observational, so patients continue their usual care while data is collected. Participation involves preoperative assessments with no additional treatments or interventions required.
CONDITIONS
Brief Title
Frailty, Hip Fractures and Inflammatory Biomarkers
Research Team
E
Eleni Arnaoutoglou, Professor
M
Maria Ntalouka, MD, PhD, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here